Idarucizumab: the first FDA-approved direct oral anticoagulant reversal agent

2016 ◽  
Vol 14 (1) ◽  
pp. 6-7
Author(s):  
Dana Angelini ◽  
Alok Khorana
Keyword(s):  
Oral Anticoagulant ◽  
Direct Oral Anticoagulant ◽  
Reversal Agent ◽  
Anticoagulant Reversal

918: Direct Oral Anticoagulant Reversal in Oncology Patients

2020 ◽  
Vol 49 (1) ◽  
pp. 456-456
Author(s):  
Liza Vo ◽  
Anne Rain Brown ◽  
Reagan Collins
Keyword(s):  
Oral Anticoagulant ◽  
Direct Oral Anticoagulant ◽  
Oncology Patients ◽  
Anticoagulant Reversal

scholarly journals Specific Antidotes for Direct Oral Anticoagulant Reversal

Circulation ◽  
2019 ◽  
Vol 140 (18) ◽  
pp. 1445-1447 ◽  
Author(s):  
Anne Godier ◽  
Anne-Céline Martin
Keyword(s):  
Oral Anticoagulant ◽  
Direct Oral Anticoagulant ◽  
Anticoagulant Reversal

scholarly journals Direct oral anticoagulant reversal

2020 ◽  
Vol 15 (6) ◽  
pp. 18-29
Author(s):  
Andrea Hafer ◽  
Lindsay McCann
Keyword(s):  
Oral Anticoagulant ◽  
Direct Oral Anticoagulant ◽  
Anticoagulant Reversal

Direct oral anticoagulant reversal: An update

Nursing ◽  
2021 ◽  
Vol 51 (6) ◽  
pp. 54-64
Author(s):  
Andrea Hafer ◽  
Lindsay McCann
Keyword(s):  
Oral Anticoagulant ◽  
Direct Oral Anticoagulant ◽  
Anticoagulant Reversal

scholarly journals Availability of Specific Direct Oral Anticoagulant Reversal Agents in US Hospitals

2021 ◽  
Vol 4 (5) ◽  
pp. e2110079
Author(s):  
Zahir Kanjee ◽  
Marissa L. McCann ◽  
Jason A. Freed
Keyword(s):  
Oral Anticoagulant ◽  
Direct Oral Anticoagulant ◽  
Reversal Agents ◽  
Anticoagulant Reversal

Direct oral anticoagulant reversal: how, when and issues faced

2017 ◽  
Vol 10 (11) ◽  
pp. 1005-1022 ◽  
Author(s):  
Mikhail S. Dzeshka ◽  
Daniele Pastori ◽  
Gregory Y.H. Lip
Keyword(s):  
Oral Anticoagulant ◽  
Direct Oral Anticoagulant ◽  
Anticoagulant Reversal
Sign in / Sign up

Export Citation Format

Share Document